Antiangiogenic therapy using nanotechnological-based delivery system

Area of Science:

• Oncology
• Biotechnology
• Nanomedicine

Background:

• Combinatorial therapy targeting angiogenesis and cancer stem cell apoptosis is a leading strategy for cancer treatment.
• There is growing interest in utilizing anti-apoptotic and anti-angiogenic biomolecules for cancer therapy.
• These biomolecules include microRNAs, small interfering RNAs, inhibitor of apoptosis protein-binding peptides, Von Hippel-Lindau tumor suppressors, and aptamers.

Purpose of the Study:

• To review the potential of anti-apoptotic and anti-angiogenic biomolecules in anticancer therapy.
• To explore the role of nanotechnology in enhancing the delivery and efficacy of these therapeutic agents.

Main Methods:

• Review of current literature on cancer treatment strategies.
• Analysis of nanotechnology-based approaches for drug delivery.
• Examination of RNA-carrying cationic cell-penetrating peptides for enhanced cellular uptake.

Main Results:

• Nanotechnology, specifically RNA-carrying cationic cell-penetrating peptides, can protect biomolecules from enzymatic digestion.
• These nanocarriers enhance the cellular internalization of therapeutic biomolecules.
• This approach holds potential for improved anticancer therapy by targeting angiogenesis and cancer stem cells.

Conclusions:

• The combination of anti-angiogenic and apoptosis-inducing strategies is highly recommended for cancer treatment.
• Nanotechnology offers a viable method for the effective delivery of therapeutic biomolecules.
• Exploiting nanotechnology with cell-penetrating peptides can overcome challenges in enzymatic degradation and cellular uptake, paving the way for advanced cancer therapies.